Announcements Trials

Browse Landscape

Phase

Status

Terminated 4 Completed 3 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 9 Magnetic Resonance Spectroscopy 7 Biopsy 6 Nivolumab 4 Capecitabine 4 Bevacizumab 4 Radiosurgery 3 Paclitaxel 3 Irinotecan 3 Fluorouracil 3 Everolimus 3 Docetaxel 3 Cyclophosphamide 3 Cisplatin 3 trifluridine tipiracil drug combination 2 spartalizumab 2 pembrolizumab 2 lenvatinib 2 decitabine and cedazuridine drug combination 2 daratumumab 2 Vincristine 2 Taxes 2 Radiation 2 Prednisone 2 Pemetrexed 2 Oxaliplatin 2 Mitoxantrone 2 Leucovorin 2 Etoposide 2 Epirubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × romiplostim × Clear all

NCT04427306 2023-09-15

Neoadjuvant T-VEC in High Risk Early Melanoma

University of California, Davis

Phase 2 Suspended

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡